Renal services provider Fresenius Medical Care has announced it will locate its East Coast manufacturing facility in Knoxville, creating 665 jobs in the coming years.
The Food and Drug Administration said Tuesday it approved a nerve-stimulating headband as the first medical device to prevent migraine headaches.
Scientists have modified genes in the blood cells of HIV patients to help them resist the AIDS virus, and say the treatment seems safe and promising.
Dr. Michael Heggeness is working on a $1.6 million research product — a "bone putty" — that could be a viable alternative to typical treatment options for combat-related trauma issues.
Check out some of this week's top headlines from across Manufacturing.net, from a phone that can self-destruct from an airplane manufacturer to more stress for Detroit from the United Auto Workers union.
In a report published Tuesday, House Republicans say the FDA's computer surveillance may have overstepped federal laws designed to protect government whistleblowers. Using software that took rapid fire screen shots of employees' computers, the FDA picked up emails from the five whistleblowers to members of Congress.
Maybe we can transport patients with hover-stretchers and flying ambulances, too. Announcements like this are bound to raise a few eyebrows, but we live in a world where 3D-printed hearts and other highly advanced surgical procedures are slowly becoming commonplace.
A federal judge has ruled in favor of a manufacturer in a lawsuit brought by a Texas woman who claimed her pelvic pain was caused by implanted surgical mesh. U.S. District Judge Joseph R. Goodwin on Tuesday dismissed Carolyn Lewis' lawsuit against Johnson & Johnson subsidiary Ethicon in the middle of a jury trial that began Feb. 10.
European researchers have taken a step toward prosthetics with a sense of touch: They created a robotic hand that let an amputee feel differences in the shape and hardness of different objects, and adjust his grasp in response.
A kinder, gentler approach to one of the most dreaded exams in medicine is on the way: U.S. regulators have cleared a bite-size camera to help screen patients who have trouble with colonoscopies. The ingestible pill camera from Given Imaging is designed to help doctors spot polyps and other early signs of colon cancer.
About 20 percent of the studies were not completed for reasons that had nothing to do with the treatment's safety or effectiveness, both legitimate reasons for ending a study early. Poor accrual — the inability to enroll enough patients in enough time to finish the study — led to nearly 40 percent of premature endings.
Forget being sneezed on: Government scientists are deliberately giving dozens of volunteers the flu by squirting the live virus straight up their noses. It may sound bizarre, but the rare type of research is a step in the quest for better flu vaccines. It turns out that how the body fends off influenza remains something of a mystery.
In a news release, Tennessee Economic and Community Development Commissioner Bill Hagerty says the company will invest $25 million in manufacturing equipment and building and infrastructure improvements in Morristown.
The National Newspaper Publishers Association and National Association of Black Owned Broadcasters argued that the ads should be disseminated through their outlets because the black community has been disproportionally targeted by tobacco companies and harmed by smoking.
Did you ever wonder who is involved in the creation and promulgation of these standards? Most people have no idea – and it’s an incredibly important piece of business intelligence to have, since those at the table where standards are developed have the opportunity to shape the specifications and market acceptance of products and systems for every industry.
The laboratory test from Affymetrix detects variations in patients' chromosomes that are linked to Down syndrome, DiGeorge syndrome and other developmental disorders. About 2 to 3 percent of U.S. children have some sort of intellectual disability, according to the National Institutes of Health.
Sandwiched in this lens are two twinkling glitter-specks loaded with tens of thousands of miniaturized transistors. It's ringed with a hair-thin antenna. Together these remarkable miniature electronics can monitor glucose levels in tears of diabetics and then wirelessly transmit them to a handheld device.
Johnson & Johnson is being offered $4.15 billion by The Carlyle Group for its Ortho-Clinical Diagnostics business.The New Brunswick, N.J., company has until the end of March to decide whether to accept the offer.
A federal jury ruled that medical device maker Medtronic infringed on a patent held by Edwards Lifesciences and ordered Medtronic to pay its competitor about $390 million in damages. Edwards said it will seek a permanent injunction to stop Medtronic's CoreValve system from going on sale in the U.S.
CareFusion Corp. has agreed to pay $40.1 million to settle allegations it paid kickbacks and promoted its medical technology products for uses not approved by the Food and Drug Administration. The Justice Department announced the settlement Thursday with the California-based company of a whistleblower lawsuit unsealed in U.S. District Court in Kansas.
The University of Minnesota is recruiting students for a new master's program in medical device innovation. The program is under the Technological Leadership Institute, part of the university's College of Science and Engineering. The new curriculum is aimed at preparing students for managing the challenges of the medical device industry.
The businesses, which had combined annual revenue of about $250 million in 2013, will become part of GE Healthcare's life sciences unit. GE said that the transaction allows it to expand its offering of technologies for the discovery and manufacturing of new medicines, vaccines and diagnostics in its life sciences business.
Vaccines did not cause the deaths of nine children shortly after they were inoculated for hepatitis in a Chinese government program and no links have been found in eight other cases still being investigated, health officials said Friday after safety concerns arose.
The probe was launched after provincial and health authorities separately reported that since November, about a half-dozen babies died shortly after receiving hepatitis B vaccine made by Biokangtai. One case has been ruled out while the others are still being investigated.
Airgas Inc., which sells gases and equipment to hospitals and industrial companies, said Friday that it is increasing prices on helium by 20 percent because it is costing it more to obtain and distribute the gas. The company said the Bureau of Land Management, which supplies a significant portion of helium in the U.S., is charging helium refiners more for the gas.